Synopsis
0
KDMF
0
NDC API
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
10
PharmaCompass offers a list of Levomepromazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levomepromazine manufacturer or Levomepromazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levomepromazine manufacturer or Levomepromazine supplier.
PharmaCompass also assists you with knowing the Levomepromazine API Price utilized in the formulation of products. Levomepromazine API Price is not always fixed or binding as the Levomepromazine Price is obtained through a variety of data sources. The Levomepromazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levomepromazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levomepromazine, including repackagers and relabelers. The FDA regulates Levomepromazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levomepromazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levomepromazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levomepromazine supplier is an individual or a company that provides Levomepromazine active pharmaceutical ingredient (API) or Levomepromazine finished formulations upon request. The Levomepromazine suppliers may include Levomepromazine API manufacturers, exporters, distributors and traders.
click here to find a list of Levomepromazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levomepromazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Levomepromazine active pharmaceutical ingredient (API) in detail. Different forms of Levomepromazine DMFs exist exist since differing nations have different regulations, such as Levomepromazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levomepromazine DMF submitted to regulatory agencies in the US is known as a USDMF. Levomepromazine USDMF includes data on Levomepromazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levomepromazine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levomepromazine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Levomepromazine Drug Master File in Japan (Levomepromazine JDMF) empowers Levomepromazine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Levomepromazine JDMF during the approval evaluation for pharmaceutical products. At the time of Levomepromazine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Levomepromazine suppliers with JDMF on PharmaCompass.
A Levomepromazine CEP of the European Pharmacopoeia monograph is often referred to as a Levomepromazine Certificate of Suitability (COS). The purpose of a Levomepromazine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levomepromazine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levomepromazine to their clients by showing that a Levomepromazine CEP has been issued for it. The manufacturer submits a Levomepromazine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levomepromazine CEP holder for the record. Additionally, the data presented in the Levomepromazine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levomepromazine DMF.
A Levomepromazine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levomepromazine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levomepromazine suppliers with CEP (COS) on PharmaCompass.
A Levomepromazine written confirmation (Levomepromazine WC) is an official document issued by a regulatory agency to a Levomepromazine manufacturer, verifying that the manufacturing facility of a Levomepromazine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levomepromazine APIs or Levomepromazine finished pharmaceutical products to another nation, regulatory agencies frequently require a Levomepromazine WC (written confirmation) as part of the regulatory process.
click here to find a list of Levomepromazine suppliers with Written Confirmation (WC) on PharmaCompass.
Levomepromazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levomepromazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levomepromazine GMP manufacturer or Levomepromazine GMP API supplier for your needs.
A Levomepromazine CoA (Certificate of Analysis) is a formal document that attests to Levomepromazine's compliance with Levomepromazine specifications and serves as a tool for batch-level quality control.
Levomepromazine CoA mostly includes findings from lab analyses of a specific batch. For each Levomepromazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levomepromazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Levomepromazine EP), Levomepromazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levomepromazine USP).
